New study tests common drug to make fibroid surgery safer
NCT ID NCT07286188
First seen Jan 11, 2026 · Last updated May 14, 2026 · Updated 20 times
Summary
This study tests whether giving misoprostol (a drug often used for other purposes) before hysteroscopic fibroid removal can reduce the amount of fluid that enters the body during surgery. Too much fluid can be dangerous. About 40 women with small fibroids will receive either misoprostol or a placebo rectally before their procedure. The main goal is to see if the drug helps keep fluid levels safer.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HYSTEROSCOPY / METHODS are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
-
Contact
Email: •••••@•••••
Locations
-
Northwestern
RECRUITINGChicago, Illinois, 60611, United States
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.